Skip to main content
Clinical Trials/NCT05769335
NCT05769335
Completed
Not Applicable

The Effects of Caloric Restriction Plus Time Restriction on Glycemia, Circadian Rhythms and Cardiometabolic Health

University of Adelaide1 site in 1 country114 target enrollmentMarch 15, 2023
ConditionsObesity

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University of Adelaide
Enrollment
114
Locations
1
Primary Endpoint
Glucose area under curve (AUC) after 3 meals
Status
Completed
Last Updated
11 months ago

Overview

Brief Summary

Type 2 diabetes and cardiovascular disease are an increasing problem in Australia and around the world, and are partly linked to increased rates of obesity, together with sedentary lifestyles. This study will compare caloric restriction (CR) diets that restrict the amount of food that is eaten with CR diets that also restrict the time that the food is eaten, to either early or late in the day, on risk factors for type 2 diabetes and cardiovascular diseases over 2 months.

Detailed Description

In a parallel groups design, a total of 114 individuals will be recruited. After a two-week lead in and collection of data from activity monitors and continuous glucose monitors, plus a 28 hour (h) metabolic ward in-patient stay, participants will be randomised into one of three groups (eCR, 8-hour early time restriction + calorie restriction (e.g. 8:00-16:00); dCR, 8-hour delayed time restriction + calorie restriction (e.g. 12:00-20:00); CR, caloric restriction (\>12 hour eating window (e.g. 8:00-20:00). All participants will receive individualised menus and foods that will be delivered to their homes by a supermarket delivery service at energy balance for 1 week (baseline) and at 70% of energy balance for a further 8 weeks. Repeat assessment occurs from 6-8 weeks with the final metabolic ward stay at 8-weeks to assess changes in primary and secondary outcomes. There are three preplanned sub-studies from the parent trial: A. OMIT-Immune sub-study All participants will have blood samples collected at six timepoints over 24 hours and stool samples will be collected at two timepoints in a subset. The aims of this sub-study are to 1) characterize the changes in 24 h rhythm (mesor, amplitude and acrophase) of immune cells by flow cytometry over 24 hours, 2) describe the changes in the diversity of bacterial in response to intervention and 3) compare the effects of 8 weeks of CR versus eCR and dCR on immune profiles and gut microbiome. B. OMIT-BP sub-study All participants will have blood and urine samples collected at six timepoints over 24 hours. A subset of participants will wear 24 h ambulatory blood pressure monitors. The aims of this sub-study are to compare the effects of CR versus eCR and dCR on 1) the 24-hour profile of blood pressure assessed by ambulatory blood pressure monitoring, 2) Plasma markers of blood pressure regulation and 3) markers of renal function. We hypothesise that both eCR and dCR will alter and enhance these parameters and markers in comparison to CR. Changes in the circadian mesor, amplitude and acrophase in: systolic blood pressure, diastolic blood pressure, heart rate, pulse pressure, mean arterial pressure, nocturnal blood pressure dipping, morning blood pressure surge, plasma renin, aldosterone, creatinine, Urinary potassium, sodium, cortisol, creatinine. C. OMIT- Six month follow up. All participants will be instructed to continue their respective diet intervention and return to the clinic after an additional 16 weeks for a fasting blood sample and assessment of body composition. The aims of this sub-study are to 1) compare the 6 months effects of CR versus eCR and dCR on body composition and fasting blood samples metabolic health from baseline; 2) explore the factors that drive the intention-behaviour gap (describing the failure to translate intentions into action) relation to diet adherence. We hypothesize that participants will maintain the intervention-induced improvements in behavioural and metabolic health outcomes. Additionally, changes in body weight, waist and hip circumference, lean mass, fat mass, blood pressure, glycated hemoglobin, fasting plasma glucose, insulin, total cholesterol, LDL, HDL, triglycerides are assessed.

Registry
clinicaltrials.gov
Start Date
March 15, 2023
End Date
April 17, 2025
Last Updated
11 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

A/Prof Leonie Heilbronn

Group Leader, Obesity and Metabolism

University of Adelaide

Eligibility Criteria

Inclusion Criteria

  • Overweight or obesity (BMI 25.1 - 44.9 kg/m2)
  • Elevated waist circumference (race specific),
  • Elevated fasting blood glucose (\>5.6 mmol/L).

Exclusion Criteria

  • A personal history/diagnosis (self-reported) of:
  • diabetes (type 1 or 2)
  • major psychiatric disorders (schizophrenia, major depressive disorder, bipolar disorder, eating disorders)
  • gastrointestinal disorders/disease (including malabsorption)
  • haematological disorders (i.e. thalassemia, iron-deficiency anaemia)
  • obstructive sleep apnea
  • night eating syndrome
  • diagnosis or treatment of cancer in the past 3 years (excluding non-melanoma skin cancer)
  • significant liver or kidney diseases that require ongoing medical care
  • previous or planned gastro-intestinal surgery (including bariatric surgery)

Outcomes

Primary Outcomes

Glucose area under curve (AUC) after 3 meals

Time Frame: 8 weeks

Change in glucose AUC after 3 meals

Secondary Outcomes

  • Insulin area under the curve (AUC)(8 weeks)
  • Fasting insulin(8 weeks)
  • Change in glycated hemoglobin (HbA1c)(8 weeks)
  • Fasting glucose(8 weeks)

Study Sites (1)

Loading locations...

Similar Trials